MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index | BMC Cancer | Full Text

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index | BMC Cancer | Full Text

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index

Treatment resistance is a major clinical challenge of diffuse large B-cell lymphoma (DLBCL) where approximately 40% of the patients have refractory disease or relapse. Since DLBCL is characterized by great cli...

Authors:Hanne Due, Rasmus Froberg Brøndum, Ken H. Young, Martin Bøgsted and Karen Dybkær

Citation:BMC Cancer 2020 20:237

Content type:Research article

Published on: 20 March 2020

• ViewFull Text
 
• ViewPDF